Regulation 221 Sale or supply of medicinal products subject to general sale
A person (“P”) may not sell or supply, or offer for sale or supply, a medicinal product that is subject to general sale elsewhere than at F1or from a registered pharmacy unless the following conditions are met.
Condition A is that the place at F2or from which the medicinal product is sold, supplied, or offered for sale or supply, consists of premises of which P is the occupier and which P is able to close so as to exclude the public.
Condition B is that—
the medicinal product was made up for sale in its immediate and outer packaging elsewhere than at the place at F3or from which it is sold, supplied, or offered for sale or supply; and
the immediate and outer packaging has not been opened since the product was made up for sale in it.
Condition C is that, if the medicinal product is of a kind specified in Schedule 15, it is presented for sale in accordance with the requirements specified in that Schedule for a product of that kind.
This regulation is subject to Chapter 3.
Annotations
Textual amendments
- F1
Words in reg. 221(1) inserted (1.10.2025) by The Human Medicines (Amendments Relating to Hub and Spoke Dispensing etc.) Regulations 2025 (S.I. 2025/758), regs. 1(2), 8(2)
- F2
Words in reg. 221(2) inserted (1.10.2025) by The Human Medicines (Amendments Relating to Hub and Spoke Dispensing etc.) Regulations 2025 (S.I. 2025/758), regs. 1(2), 8(3)
- F3
Words in reg. 221(3)(a) inserted (1.10.2025) by The Human Medicines (Amendments Relating to Hub and Spoke Dispensing etc.) Regulations 2025 (S.I. 2025/758), regs. 1(2), 8(4)
Notes on Part 12
Modifications
- C1
Pt. 12 modified (E.W.) (1.10.2015) by The Nicotine Inhaling Products (Age of Sale and Proxy Purchasing) Regulations 2015 (S.I. 2015/895), regs. 1(3), 4(2)